Search hospitals
>
California
>
Los Angeles
David Geffen School of Medicine at UCLA
Claim this profile
Los Angeles, California 90095
Global Leader in HIV Infection
Global Leader in Pulmonary Arterial Hypertension
Conducts research for Human Immunodeficiency Virus Infection
Conducts research for Idiopathic Pulmonary Fibrosis
Conducts research for Duchenne Muscular Dystrophy
232 reported clinical trials
10 medical researchers
Summary
David Geffen School of Medicine at UCLA is a medical facility located in Los Angeles, California. This center is recognized for care of HIV Infection, Pulmonary Arterial Hypertension, Human Immunodeficiency Virus Infection, Idiopathic Pulmonary Fibrosis, Duchenne Muscular Dystrophy and other specialties. David Geffen School of Medicine at UCLA is involved with conducting 232 clinical trials across 308 conditions. There are 10 research doctors associated with this hospital, such as Gary Schiller, MD, Perry Shieh, MD, PhD, Susan Perlman, MD, and Jaime G Deville, M.D..
Area of expertise
HIV Infection
David Geffen School of Medicine at UCLA has run 18 trials for HIV Infection. Some of their research focus areas include:
Pulmonary Arterial Hypertension
David Geffen School of Medicine at UCLA has run 15 trials for Pulmonary Arterial Hypertension.
Top PIs
Gary Schiller, MD
UCLA Medical Center
7 years of reported clinical research
Perry Shieh, MD, PhD
David Geffen School of Medicine at UCLA
2 years of reported clinical research
Susan Perlman, MD
University of California - Los Angeles
5 years of reported clinical research
Jaime G Deville, M.D.
David Geffen School of Medicine at UCLA (CRS 5112)
4 years of reported clinical research
Clinical Trials running at David Geffen School of Medicine at UCLA
Alpha-1 Antitrypsin Deficiency
Seizures
Myelofibrosis
Epilepsy
Facioscapulohumeral Muscular Dystrophy
Chronic Lymphocytic Leukemia
Follicular Lymphoma
Lymphoma
Peripheral T-Cell Lymphoma
Emphysema
SAR447537
for Emphysema
Phase 2 open label extension study to evaluate SAR447537 (INBRX-101) in adults with AATD emphysema
Recruiting
1 award
Phase 2
4 criteria
Fazirsiran
for Alpha-1 Antitrypsin Deficiency
This trial is testing fazirsiran, a drug that may reduce liver scarring and improve liver health, in patients with liver fibrosis. The drug works by decreasing harmful proteins and reducing inflammation in the liver.
Recruiting
1 award
Phase 3
8 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at David Geffen School of Medicine at UCLA?
David Geffen School of Medicine at UCLA is a medical facility located in Los Angeles, California. This center is recognized for care of HIV Infection, Pulmonary Arterial Hypertension, Human Immunodeficiency Virus Infection, Idiopathic Pulmonary Fibrosis, Duchenne Muscular Dystrophy and other specialties. David Geffen School of Medicine at UCLA is involved with conducting 232 clinical trials across 308 conditions. There are 10 research doctors associated with this hospital, such as Gary Schiller, MD, Perry Shieh, MD, PhD, Susan Perlman, MD, and Jaime G Deville, M.D..
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.